Should Methotrexate plus Calcineurin Inhibitors Be Considered Standard of Care for Prophylaxis of acute Graft-versus-Host Disease?

Abstract
No abstract available
Funding Information
  • NIH (CA142106, CA78902, CA18029, CA15704, HL36444)

This publication has 98 references indexed in Scilit: